Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 2Phase EARLY_PHASE1 1

Status

Terminated 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 4Thoracic 3Myeloid 3Plasma cell 2Lymphoid 2Gastrointestinal 2Dermatologic 2CNS 2Sarcoma 1Other solid neoplasm 1Other 1Head & Neck 1Gynecologic 1

Conditions

Brain Neoplasms 133Glioblastoma 92Astrocytoma 44Neuroblastoma 40Glioma 40Central Nervous System Neoplasms 38Neoplasms 26Breast Neoplasms 25Neoplasm Metastasis 24Oligodendroglioma 20Gliosarcoma 19Carcinoma, Non-Small-Cell Lung 18Lymphoma, Follicular 14Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Medulloblastoma 13Burkitt Lymphoma 13Testicular Neoplasms 12Lymphoma, T-Cell, Cutaneous 12Lymphoma, Non-Hodgkin 12Lymphoma, Mantle-Cell 12Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Leukemia, Lymphocytic, Chronic, B-Cell 12Hodgkin Disease 12Sezary Syndrome 11Primary Myelofibrosis 11Mycosis Fungoides 11Leukemia, Myeloid, Chronic-Phase 11

Interventions

Radiotherapy 1Methylphenidate 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Depression × CNS × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT02443194 2015-12-03

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Tel-Aviv Sourasky Medical Center

Phase 3 Terminated
50 enrolled
CNS

Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡